Gritstone Bio Inc (GRTS) concluded trading on Thursday at a closing price of $2.46, with 4.3 million shares of worth about $10.57 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 31.55% during that period and on Thursday, February 01 price saw a gain of about 2.93%. Currently the company’s common shares owned by public are about 95.34M shares, out of which, 87.79M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 7 times over the past 12 months. They bought 1,691,502 shares in 7 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
However, the stock later moved at a day high price of 2.4976, or with a gain of 2.93%. Stock saw a price change of -13.68% in past 5 days and over the past one month there was a price change of 12.84%. Year-to-date (YTD), GRTS shares are showing a performance of 20.59% which decreased to -22.64% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.14 but also hit the highest price of $3.53 during that period. The average intraday trading volume for Gritstone Bio Inc shares is 1.79 million. The stock is currently trading -3.91% below its 20-day simple moving average (SMA20), while that difference is up 22.33% for SMA50 and it goes to 22.95% higher than SMA200.
Gritstone Bio Inc (NASDAQ: GRTS) currently have 95.34M outstanding shares and institutions hold larger chunk of about 45.05% of that.
The stock has a current market capitalization of $234.54M and its 3Y-monthly beta is at 0.37. It has posted earnings per share of -$1.30 in the same period. It has Quick Ratio of 3.88 while making debt-to-equity ratio of 1.29. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for GRTS, volatility over the week remained 10.19% while standing at 11.64% over the month.
Analysts are in expectations that Gritstone Bio Inc (GRTS) stock would likely to be making an EPS of $Gritstone bio, Inc. in the current quarter, while forecast for next quarter EPS is $2.46 and it is $Stocks for next year. For the current quarter EPS, analysts have given the company a lowest target $Grifols, S.A. which is $CarParts.com, Inc. at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of $Galera Therapeutics, Inc. in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 0.88% while it is estimated to increase by 16.31% in next year.
